4/A: Valvoline CFO's Stock Appreciation Rights Exercise Price Corrected in Amended SEC Filing
Insider Transaction Amendment
Valvoline Inc.'s Chief Financial Officer, J. Kevin Willis, filed an amended Form 4 to correct the exercise price of 27,050 stock appreciation rights granted on June 2, 2025, setting it at $34.36.
Summary
- J. Kevin Willis, Chief Financial Officer of Valvoline Inc. (VVV), filed an amended Form 4 on June 5, 2025.
- The amendment corrects the exercise price of 27,050 Stock Appreciation Rights (SARs) granted on June 2, 2025.
- The corrected exercise price for these FY 2025 SARs is $34.36.
- The SARs have a vesting schedule where 50% vest on the first anniversary of the grant date, and 25% vest on each of the second and third anniversaries.
- The expiration date for these SARs is June 2, 2035.
- Following this transaction, Mr. Willis beneficially owns 27,050 SARs directly.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing correcting a detail in an executive's equity grant. It contains no positive or negative operational or financial news, thus maintaining a neutral sentiment.
Positives
- The grant of Stock Appreciation Rights to the Chief Financial Officer aligns management's interests with shareholder value creation.
- The transparency of correcting the exercise price through an amended filing demonstrates adherence to regulatory disclosure requirements.
Negatives
- No negative information is presented in this amendment, which primarily serves to correct a previously reported detail.
Risks
- This filing does not introduce new risks; it is a correction to an existing equity grant disclosure.
Future Outlook
This document, an amendment to an insider transaction report, does not provide any forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Industry Context
This filing is a routine insider transaction disclosure and correction, specific to Valvoline Inc.'s executive compensation. It does not provide broader insights into industry trends or competitive dynamics within the lubricants or automotive services sector.
Comparison to Industry Standards
- This document reports a specific equity grant and its correction for an executive. It does not contain information that allows for a direct comparison of company performance or executive compensation structures against global industry benchmarks or specific comparable companies/projects.
Stakeholder Impact
- Shareholders: The grant of Stock Appreciation Rights to the CFO aligns his financial incentives with the company's stock performance, potentially benefiting shareholders if the stock price increases.
Next Steps
- The vesting of the Stock Appreciation Rights will occur in three tranches: 50% on June 2, 2026, 25% on June 2, 2027, and the final 25% on June 2, 2028.
- The Stock Appreciation Rights will expire on June 2, 2035.
Key Dates
| Date | Description |
|---|---|
| 06/02/2025 | Grant date of FY 2025 Stock Appreciation Rights to J. Kevin Willis. |
| 06/03/2025 | Original filing date of Form 4. |
| 06/05/2025 | Amendment filing date of Form 4/A to correct the exercise price. |
| 06/02/2026 | First anniversary of grant date, when 50% of SARs vest. |
| 06/02/2027 | Second anniversary of grant date, when an additional 25% of SARs vest. |
| 06/02/2028 | Third anniversary of grant date, when the final 25% of SARs vest. |
| 06/02/2035 | Expiration date of the Stock Appreciation Rights. |
Keywords
Valvoline, VVV, SEC Filing, Form 4/A, Insider Transaction, Stock Appreciation Rights, SARs, Equity Compensation, Chief Financial Officer, J. Kevin Willis, Corporate Governance, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.